Seattle, Oct. 09, 2017 --
Veterinary oncology is giving dogs a chance when faced with a cancer diagnosis, and medical insurance for pets is helping pet owners manage the financial impact associated with this advanced care. Trupanion, a leader in medical insurance for cats and dogs, has seen an increase in cancer-related claims as treatment options become more accessible. Since January 2017, the Trupanion policy has paid over $6 million in cancer-related claims for dogs alone.
Many cancer treatments available to humans are also being used to treat pets. This includes immunotherapy, surgery, radiation, chemotherapy and other therapies. Veterinary oncologists specialize in cutting-edge treatments to give pets the best quality of life when faced with a cancer diagnosis. But these advanced treatments come at a cost.
Deanna P., a veterinary technician in Seekonk, Massachusetts, experienced this firsthand when her German Shepherd, Kendra, developed anal gland adenocarcinoma. Kendra’s treatment involved surgeries, medication, chemotherapy, radiation, ultrasounds, imaging, acupuncture, Chinese medicine, supplements, physical therapy, and eventually hospice care—totaling almost $50,000. “In this time of state-of-the-art medical advancement in the health management and care of our pets, for me, pet medical insurance is just as mandatory as microchipping and routine veterinary care,” Deanna said.
The decision to move forward with cancer treatment for a pet can be significantly influenced by the financial burden that comes with some treatment options. Medical insurance for cats and dogs helps remove that burden so owners can make the best decision for their pet regardless of cost.
When Lori G. of Groton, Connecticut, found out her Golden Retriever, Kelly, had soft tissue sarcoma, she was faced with a tough choice. Kelly was just 5 years old, happy and otherwise healthy. “The doctors at Vet Cancer Center recommended an aggressive treatment plan due to the advanced stage of the tumor,” Lori said. “I was at the point where I had to make the hard decision. Do I move forward? Do I put Kelly though this? How will her quality of life be affected? What is the prognosis?”
Lori decided to move forward with Kelly’s treatment. “Because of Trupanion, I didn’t have to address the biggest deciding factor that most people face—can I afford this?” Lori said. “The cost of the treatment was never a factor in my decision-making process.” Her insurance covered over $18,000 in veterinary expenses.
Veterinary oncology is more accessible now than ever, and medical insurance for pets can help cover the cost of these treatments, allowing pet owners to focus on their pet and not worry about finances. This coverage can give pet owners more accessible and advanced treatment options to help improve a pet’s quality of life, without creating a financial burden during an already difficult time.
About Trupanion
Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For almost two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information please visit trupanion.com.
[email protected] 206-607-1930


Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Bill Ackman Eyes New Fund to Bet Against Market Complacency
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 



